ESR1 and cancer: Although this approach does not simulate physiological conditions in the human body, further investigation into the effects of differentiation with a selective ERβ agonist on cancer cell migration could yield a deeper understanding of the impact of ERα and ERβ activation on endothelial and cancer cells.